Avantor (AVTR) PT Lowered to $11 by BofA Following Soft FY 2026 Guidance

Group 1 - Avantor Inc. (NYSE:AVTR) is considered one of the most undervalued mid-cap stocks currently available for investment [1] - Bank of America analyst Michael Ryskin lowered the price target for Avantor to $11 from $13 while maintaining a Neutral rating due to a weak FY 2026 guidance [1][2] - Citi also reduced its price target for Avantor to $11 from $13, citing Q4 2025 results and FY 2026 guidance that fell below expectations, particularly highlighting the low earnings-per-share guidance of $0.15 to $0.16 [3] Group 2 - Avantor provides essential products and services across various sectors including biopharma, healthcare, education, government, advanced technologies, and applied materials globally [4]